PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.16%
Negative revenue growth while NXPI stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.27%
Negative gross profit growth while NXPI is at 1.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-19.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-24.91%
Negative net income growth while NXPI stands at 4.59%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.00%
Negative EPS growth while NXPI is at 5.13%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-24.83%
Negative diluted EPS growth while NXPI is at 5.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.21%
Share reduction while NXPI is at 0.60%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.21%
Reduced diluted shares while NXPI is at 0.94%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
16.89%
Dividend growth under 50% of NXPI's 49.11%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-11.95%
Negative OCF growth while NXPI is at 9.12%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.67%
Negative FCF growth while NXPI is at 10.05%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
48.40%
Similar 10Y revenue/share CAGR to NXPI's 51.96%. Walter Schloss might see both firms benefiting from the same long-term demand.
14.96%
5Y revenue/share CAGR at 50-75% of NXPI's 23.91%. Martin Whitman would worry about a lagging mid-term growth trajectory.
4.75%
3Y revenue/share CAGR under 50% of NXPI's 12.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
133.26%
10Y OCF/share CAGR under 50% of NXPI's 2613.60%. Michael Burry would worry about a persistent underperformance in cash creation.
54.69%
5Y OCF/share CAGR above 1.5x NXPI's 21.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
35.00%
3Y OCF/share CAGR 1.25-1.5x NXPI's 31.71%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
117.46%
Similar net income/share CAGR to NXPI's 123.25%. Walter Schloss would see parallel tailwinds or expansions for both firms.
45.49%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
9.10%
3Y net income/share CAGR 1.25-1.5x NXPI's 6.20%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
21.96%
Below 50% of NXPI's 678.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-3.83%
Negative 5Y equity/share growth while NXPI is at 1352.49%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-9.21%
Negative 3Y equity/share growth while NXPI is at 6.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
651.36%
Dividend/share CAGR of 651.36% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
165.01%
Dividend/share CAGR of 165.01% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
79.91%
3Y dividend/share CAGR of 79.91% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-19.97%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.91%
Inventory is declining while NXPI stands at 5.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.14%
Positive asset growth while NXPI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.66%
We have a declining book value while NXPI shows 0.03%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.20%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.85%
R&D dropping or stable vs. NXPI's 7.07%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.26%
SG&A growth well above NXPI's 1.81%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.